Showing results (1541-1550 of 2,459) with videos related to
Sort By:
Pageof 246
Molecules (Basel, Switzerland)|April 12, 2022
Development of Bicyclo[3.1.0]hexane-Based A3 Receptor Ligands: Closing the Gaps in the Structure-Affinity RelationshipsJan Phillip Lemmerhirt, Andreas Isaak, Rongfang Liu, et al.Journal of Neurochemistry|August 29, 2012
Molecular determinants of A2AR-D2R allosterism: role of the intracellular loop 3 of the D2RVíctor Fernández-Dueñas, Maricel Gómez-Soler, Kenneth A Jacobson, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Activation of murine lung mast cells by the adenosine A3 receptorHongyan Zhong, Sergiy G Shlykov, Jose G Molina, et al.Medchemcomm|August 9, 2019
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines to develop functionalized ligands to target adenosine receptors: fluorescent ligands as an exampleStephanie Federico, Enrico Margiotta, Silvia Paoletta, et al.Neuroscience Letters|March 31, 1988
Autoradiographic localization of mouse brain adenosine receptors with an antagonist ([3H]xanthine amine congener) ligand probeJ Deckert, P F Morgan, J C Bisserbe, et al.Current Eye Research|September 9, 2005
The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressureHui Yang, Marcel Y Avila, Kim Peterson-Yantorno, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|May 29, 2003
Patient education strategies to improve pneumococcal vaccination rates: randomized trialDonna M Thomas, Susan M Ray, Felicia J Morton, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 25, 2016
Greater Trochanteric Pain Syndrome: Percutaneous Tendon Fenestration Versus Platelet-Rich Plasma Injection for Treatment of Gluteal TendinosisJon A Jacobson, Corrie M Yablon, P Troy Henning, et al.The Annals of Thoracic Surgery|October 30, 2004
ERBB2 amplifications in esophageal adenocarcinomaPeter S Dahlberg, Blake A Jacobson, Ganesh Dahal, et al.Journal of Clinical Lipidology|December 16, 2014
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trialPatrick M Moriarty, Terry A Jacobson, Eric Bruckert, et al.Pageof 246